ImmunityBio, Inc. (IBRX)

Nasdaq · Healthcare · Biotechnology
$6.02-8.37%As of 2026-11-22 · USD
Last session low $6.00Last session high $6.53
52-week low $1.9552-week high $12.43
Market cap
$6.40B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)36.0In the neutral range (30 to 70)
MACD (12, 26, 9)-0.69Below its signal line (-0.59); histogram -0.10
Bollinger %B (20, 2)17%Inside the bands (5.29 to 9.54)
SMA 207.41Price is 18.8% below
SMA 508.42Price is 28.5% below
SMA 2007.98Price is 24.6% below
ATR (20)10.80% of priceAverage true range per day
52-week position39%In the middle of the 1.95 to 12.43 range

About ImmunityBio, Inc.

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases.

Latest fiscal yearEnded 2025-12-31: revenue of $113.29M and an operating margin of -226.0%.

More in Biotechnology